Clinical Trials
4
Active:2
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Active, not recruiting
- Conditions
- Chronic Kidney Disease Stage 2Chronic Kidney Disease Stage 1Diabetic Kidney DiseaseChronic Kidney DiseasesChronic Kidney Disease Stage 3
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Renalytix AI, Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT05198284
- Locations
- 🇺🇸
Mount Sinai Health System, New York, New York, United States
Prospective Decision Impact Trial of KidneyIntelX
Active, not recruiting
- Conditions
- Diabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2Chronic Kidney Disease, Stage 3 (Moderate)
- First Posted Date
- 2021-07-14
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Renalytix AI, Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT04960514
- Locations
- 🇺🇸
Atrium Health Wake Forest Baptist - Family Medicine - Piedmont Plaza, Winston-Salem, North Carolina, United States
Real World Evidence Clinical Utility Study of KidneyIntelX
Recruiting
- Conditions
- Diabetic Kidney DiseaseChronic Kidney Diseases
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Renalytix AI, Inc.
- Target Recruit Count
- 10000
- Registration Number
- NCT04802395
- Locations
- 🇺🇸
Mount Sinai Health System, New York, New York, United States
Decision Impact Trial of KidneyIntelX
Recruiting
- Conditions
- Diabetic Kidney Disease
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Renalytix AI, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT04791358
- Locations
- 🇺🇸
Delmar Family Medicine, Slingerlands, New York, United States
News
No news found